Clinical effect evaluation of Yanqing Zhitong Balm Acupoint Application on cervical spondylotic radiculopathy

注册号:

Registration number:

ITMCTR2000003750

最近更新日期:

Date of Last Refreshed on:

2020-08-27

注册时间:

Date of Registration:

2020-08-27

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

延青止痛膏穴位贴敷治疗神经根型颈椎病的临床疗效评价

Public title:

Clinical effect evaluation of Yanqing Zhitong Balm Acupoint Application on cervical spondylotic radiculopathy

注册题目简写:

English Acronym:

研究课题的正式科学名称:

延青止痛膏穴位贴敷治疗神经根型颈椎病的临床疗效评价

Scientific title:

Clinical effect evaluation of Yanqing Zhitong Balm Acupoint Application on cervical spondylotic radiculopathy

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiCTR2000037105 ; ChiMCTR2000003750

申请注册联系人:

王腾腾

研究负责人:

王腾腾

Applicant:

Wang Tengteng

Study leader:

Wang Tengteng

申请注册联系人电话:

Applicant telephone:

+86 15216676635

研究负责人电话:

Study leader's telephone:

+86 15216676635

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

koudaidalong@sina.com

研究负责人电子邮件:

Study leader's E-mail:

koudaidalong@sina.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

上海市徐汇区宛平南路725号

研究负责人通讯地址:

上海市徐汇区宛平南路725号

Applicant address:

725 Wanping Road South, Xuhui District, Shanghai, China

Study leader's address:

725 Wanping Road South, Xuhui District, Shanghai, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

上海中医药大学附属龙华医院

Applicant's institution:

Longhua Hospital Affiliated to Shanghai University of traditional Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

2020LHSB066

伦理委员会批件附件:

Approved file of Ethical Committee:

View

批准本研究的伦理委员会名称:

上海中医药大学附属龙华医院伦理审查委员会

Name of the ethic committee:

Institutional Review Board Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

1990/1/1 0:00:00

伦理委员会联系人:

刘蕾

Contact Name of the ethic committee:

Liu Lei

伦理委员会联系地址:

上海市徐汇区宛平南路725号

Contact Address of the ethic committee:

725 Wanping Road South, Xuhui District, Shanghai, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

上海中医药大学附属龙华医院

Primary sponsor:

Longhua Hospital Affiliated to Shanghai University of traditional Chinese Medicine

研究实施负责(组长)单位地址:

上海市徐汇区宛平南路725号

Primary sponsor's address:

725 Wanping Road South, Xuhui District, Shanghai, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

上海中医药大学附属龙华医院

具体地址:

徐汇区宛平南路725号

Institution
hospital:

Longhua Hospital Affiliated to Shanghai University of traditional Chinese Medicine

Address:

725 Wanping Road South, Xuhui District

经费或物资来源:

上海申康医院发展中心

Source(s) of funding:

Shanghai Shenkang Hospital Development Center

研究疾病:

神经根型颈椎病

研究疾病代码:

Target disease:

Cervical spondylotic radiculopathy

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

探索性研究/预试验

Pilot clinical trial

研究目的:

验证延青止痛膏穴位贴敷治疗神经根型颈椎病的临床疗效及安全性,为临床提供高质量的循证数据。

Objectives of Study:

To verify the clinical efficacy and safety of Yan-qing-zhi-tong balm in the treatment of cervical spondylotic radiculopathy, and to provide high-quality evidence-based data for clinical practice.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

(1)临床症状、体征与影像学符合神经根型颈椎病诊断,就诊时颈部持续疼痛; (2)年龄18-70岁的男性或女性; (3)最近1个月内未参加任何药物临床试验; (4)知情同意并签署知情同意书。

Inclusion criteria

1. The patients whose clinical symptoms, signs and imaging are consistent with the diagnosis of cervical spondylotic radiculopathy have persistent neck pain; 2. Male or female aged 18-70 years; 3. Patients who have not participated in any drug clinical trial in the past month; 4. Patients with informed consent and signed informed consent.

排除标准:

(1)颈椎外伤史或接受过颈椎手术治疗者; (2)伴有明显头晕及脊髓压迫症状或影像学发现脊髓压迫者; (3)颈椎病急需手术者; (4)有皮肤过敏者; (5)孕妇、哺乳期妇女; (6)合并心脑血管、神经系统、内分泌系统等严重原发性疾病,结核,椎体畸形,恶性肿瘤及精神病患者; (7)诊断为强直性脊柱炎、类风湿关节炎者; (8)目前正参加其他临床试验者; (9)依从性差,无法满足随访要求者。

Exclusion criteria:

1. Patients with cervical spine trauma or who have received cervical spine surgery; 2. Patients with obvious symptoms of dizziness and spinal cord compression or spinal cord compression found by imaging; 3. Patients with cervical spondylosis in urgent need of surgery; 4. People with skin allergy; 5. Pregnant and lactating women; 6. Patients with severe primary diseases such as cardiovascular and cerebrovascular, nervous system and endocrine system, tuberculosis, vertebra deformity, malignant tumor and psychosis; 7. Patients diagnosed with ankylosing spondylitis or rheumatoid arthritis; 8. Currently participating in other clinical trials; 9. Poor compliance, unable to meet the follow-up requirements.

研究实施时间:

Study execute time:

From 2020-10-01

To      1990-01-01

征募观察对象时间:

Recruiting time:

From 2020-10-01

To      1990-01-01

干预措施:

Interventions:

组别:

治疗组

样本量:

100

Group:

experimental group

Sample size:

干预措施:

延青止痛膏穴位贴敷

干预措施代码:

Intervention:

acupoint application with Yan-qing-zhi-tong balm

Intervention code:

组别:

对照组

样本量:

100

Group:

control group

Sample size:

干预措施:

敷贴治疗,无添加药物

干预措施代码:

Intervention:

acupoint application with dressing, no medicine added

Intervention code:

样本总量 Total sample size : 200

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

上海

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

上海中医药大学附属龙华医院

单位级别:

三级甲等

Institution/hospital:

Longhua Hospital Affiliated to Shanghai University of traditional Chinese Medicine

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

颈部失能指数量表

指标类型:

次要指标

Outcome:

NeckDisability Index, NDI

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

患者满意度

指标类型:

次要指标

Outcome:

Patients' satisfaction

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

视觉模拟疼痛评分

指标类型:

主要指标

Outcome:

Visual analog pain score

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

SF-36 评分

指标类型:

次要指标

Outcome:

SF-36

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

征募研究对象情况:

正在进行

Recruiting

年龄范围:

最小 18
Min age years
最大 70
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

由专门人员使用spss系统生成随机数。

Randomization Procedure (please state who generates the random number sequence and by what method):

Random Numbers are generated by the specialized staff using THE SPSS system.

盲法:

对受试者施盲

Blinding:

Blind method for subjects.

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

2022年8月使用医院数据平台公开数据

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

In August 2022, the hospital data platform was used to publicize the data

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表,Epidata

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form and Epidata

数据管理委员会:

Data Managemen Committee:

Yes

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above